Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLN Mapping of Oral Cancer Using NIR Fluorescence
NCT02478138Completed
- Sponsor
- University Health Network
- Start
- May 2015
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in head and neck cancer (HNC), sponsored by University Health Network. Primary endpoint: ICG imaging to identify lymph nodes metastases in head and neck cancer. Started May 2015; status: completed.
02
Drugs
indocyanine green
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02478138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478138.